| 123.47 Real-Time Quote |  +1.47 / +1.20%Today’s Change | 67.67 Today|||52-Week Range 133.00 | +43.57% Year-to-Date |
| Which Generic Drugmaker Is Your Best Buy Today? Jun 06 / MotleyFool.com | AZN Updates on Pulmicort Respules - Analyst Blog May 28 / Zacks.com |
| CRL for Endo Health's Aveed - Analyst Blog Jun 03 / Zacks.com | Pharma M&A: defensive deals May 28 / FT.com |
| Shire Settles Lawsuit with Teva - Analyst Blog Jun 03 / Zacks.com | 1 Reason to Expect Big Things from Actavis May 28 / MotleyFool.com |
| Two Top Endo Executives Depart - Analyst Blog May 30 / Zacks.com | Bausch & Lomb - successful outcome May 27 / FT.com |
| Has Actavis Made You Any Fast Money? May 29 / MotleyFool.com | Valeant pays $8.7 billion for Bausch & Lomb May 27 / CNNMoney.com |
| Previous close | 122.00 |
| Today’s open | 122.36 |
| Day’s range | 121.69 - 123.74 |
| Volume | 104,236 |
| Average volume (3 months) | 1,653,210 |
| Market cap | $16.3B |
| Dividend yield | -- |
| Earnings growth (last year) | -63.11% |
| Earnings growth (this year) | +38.25% |
| Earnings growth (next 5 years) | +12.00% |
| Revenue growth (last year) | +29.02% |
| P/E ratio | NM |
| Price/Sales | 1.83 |
| Price/Book | 4.06 |
| Today’s change | Today’s % change | |
|---|---|---|
| ZTSZoetis Inc | -0.38 | -1.18% |
| VRTXVertex Pharmaceutica... | +1.24 | +1.59% |
| SHPGShire PLC | +0.65 | +0.66% |
| ALXNAlexion Pharmaceutic... | +2.38 | +2.56% |
| Next reporting date | July 31, 2013 |
| EPS forecast (this quarter) | $2.00 |
| Annual revenue (last year) | $5.9B |
| Annual profit (last year) | $97.3M |
| Net profit margin | 1.65% |
Sector Health Technology |
Industry Pharmaceuticals: Generic |
President, Chief Executive Officer & Director Paul M. Bisaro |
Global Chief Financial Offi cer R. Todd Joyce, CPA |
Corporate headquarters Parsippany, New Jersey |
.
